Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;68(5):1210-21.
doi: 10.1002/art.39559.

Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells

Sarah J Fleischer  1 , Capucine Daridon  1 , Vanessa Fleischer  1 , Peter E Lipsky  2 , Thomas Dörner  1
Affiliations

Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells

Sarah J Fleischer et al. Arthritis Rheumatol. 2016 May.

Abstract

Objective: Systemic lupus erythematosus (SLE) is associated with hyperactivity of B cells and abnormalities of B cell receptor (BCR) signaling. To address the linkage between dysregulated BCR signaling and increased B cell function, we assessed immediate phosphorylation events in lupus B cells.

Methods: B cells from SLE patients and healthy donors were analyzed by flow cytometry to assess phosphorylated CD22, Syk, and Akt as well as the basal expression of the BCR coreceptors CD22 and CD19. Confocal microscopy studies determined the recruitment of CD22 and the tyrosine phosphatase SH2 domain-containing phosphatase 1 to the activated BCR complex. Additionally, phosphatase activity in SLE versus healthy donor B cells was measured.

Results: B cells from SLE patients showed diminished Syk phosphorylation and reduced intracellular calcium release after BCR activation as compared to B cells from healthy donors. This was related to an enhanced activity of tyrosine, but not serine/threonine, phosphatases and was corrected by inhibition of tyrosine phosphatase activity. In contrast to reduced Syk phosphorylation after BCR activation, phosphorylation of Akt was significantly increased in SLE B cells. The disturbed balance between Syk and Akt phosphorylation was significantly correlated with B cell survival following BCR engagement. Furthermore, CD27-, but not CD27+, B cells from SLE patients displayed increased expression and phosphorylation of the inhibitory BCR coreceptor CD22.

Conclusion: These results indicate that an imbalance between serine and tyrosine phosphatases in SLE contributes to an intrinsically disturbed balance of BCR-initiated signaling pathways, resulting in enhanced survival of lupus B cells and differentiation into plasma cells.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus.
    Dörner T, Szelinski F, Lino AC, Lipsky PE. Dörner T, et al. RMD Open. 2020 Jul;6(2):e001258. doi: 10.1136/rmdopen-2020-001258. RMD Open. 2020. PMID: 32675278 Free PMC article. Review.
  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).
    Cossarizza A, Chang HD, Radbruch A, Abrignani S, Addo R, Akdis M, Andrä I, Andreata F, Annunziato F, Arranz E, Bacher P, Bari S, Barnaba V, Barros-Martins J, Baumjohann D, Beccaria CG, Bernardo D, Boardman DA, Borger J, Böttcher C, Brockmann L, Burns M, Busch DH, Cameron G, Cammarata I, Cassotta A, Chang Y, Chirdo FG, Christakou E, Čičin-Šain L, Cook L, Corbett AJ, Cornelis R, Cosmi L, Davey MS, De Biasi S, De Simone G, Del Zotto G, Delacher M, Di Rosa F, Di Santo J, Diefenbach A, Dong J, Dörner T, Dress RJ, Dutertre CA, Eckle SBG, Eede P, Evrard M, Falk CS, Feuerer M, Fillatreau S, Fiz-Lopez A, Follo M, Foulds GA, Fröbel J, Gagliani N, Galletti G, Gangaev A, Garbi N, Garrote JA, Geginat J, Gherardin NA, Gibellini L, Ginhoux F, Godfrey DI, Gruarin P, Haftmann C, Hansmann L, Harpur CM, Hayday AC, Heine G, Hernández DC, Herrmann M, Hoelsken O, Huang Q, Huber S, Huber JE, Huehn J, Hundemer M, Hwang WYK, Iannacone M, Ivison SM, Jäck HM, Jani PK, Keller B, Kessler N, Ketelaars S, Knop L, Knopf J, Koay HF, Kobow K, Kriegsmann K, Kristyanto H, Krueger A, Kuehne JF, Kunze-Schumacher H, Kvistborg P, Kwok I, Latorre D, Lenz D, Levings MK, Lino AC, Liotta F, Long HM, Lugli E, MacDonald KN, M… See abstract for full author list ➔ Cossarizza A, et al. Eur J Immunol. 2021 Dec;51(12):2708-3145. doi: 10.1002/eji.202170126. Epub 2021 Dec 7. Eur J Immunol. 2021. PMID: 34910301 Free PMC article. Review.
  • 2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus.
    Yin H, Li L, Feng X, Wang Z, Zheng M, Zhao J, Fan X, Wu W, Gao L, Zhan Y, Zhao M, Lu Q. Yin H, et al. Signal Transduct Target Ther. 2024 Nov 17;9(1):323. doi: 10.1038/s41392-024-02017-6. Signal Transduct Target Ther. 2024. PMID: 39551768 Free PMC article.
  • Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases.
    Phalke S, Aviszus K, Rubtsova K, Rubtsov A, Barkes B, Powers L, Warner B, Crooks JL, Kappler JW, Fernández-Pérez ER, Maier LA, Hamzeh N, Marrack P. Phalke S, et al. Am J Respir Crit Care Med. 2020 Oct 1;202(7):1013-1023. doi: 10.1164/rccm.201911-2151OC. Am J Respir Crit Care Med. 2020. PMID: 32501729 Free PMC article.
  • BTLA Expression and Function Are Impaired on SLE B Cells.
    Wiedemann A, Lettau M, Weißenberg SY, Stefanski AL, Schrezenmeier EV, Rincon-Arevalo H, Reiter K, Alexander T, Hiepe F, Lino AC, Dörner T. Wiedemann A, et al. Front Immunol. 2021 Apr 22;12:667991. doi: 10.3389/fimmu.2021.667991. eCollection 2021. Front Immunol. 2021. PMID: 33968071 Free PMC article.
See all "Cited by" articles

Publication types

MeSH terms

Substances